课题基金 / 基金详情

Regulation of Cardiac Development by Chromatin Modifying Enzymes

Regulation of Cardiac Development by Chromatin Modifying Enzymes
染色质修饰酶对心脏发育的调节
批准号:
10399458
负责人:
Chinmay M Trivedi
金额:
$41.88万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-04-01 至 2025-01-31

项目摘要

项目成果

Chinmay M Trivedi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Aortic valve disease is an increasingly prevalent cause of morbidity and mortality, with no current effective pharmacological treatment. An underlying pathology is often aberrant differentiation of valvular interstitial cells (VICs) leading to altered composition of extracellular matrix (ECM) and calcification. Although various factors involved in VIC differentiation have been described, the chromatin modifiers required to maintain mesenchymal identity of VICs remain largely unknown. Histone deacetylases (Hdacs) lack intrinsic DNA-binding domains but modify chromatin via their interactions with transcription factors, co-factors, and large multiprotein transcriptional complexes. We recently published that mouse embryos lacking Hdac3 within the second heart field cardiac progenitor cells exhibit complete embryonic lethality and severe cardiac developmental defects, including bicuspid and hyperplastic aortic valve. Our preliminary data suggest a novel and unexpected role of Hdac3 in postnatal aortic valve homeostasis. Hdac3-null aortic valves exhibit upregulation of a discrete set of chondrogenic genes, which are frequently elevated in human diseased aortic valves. In murine aortic valves, Hdac3 recruits components of the Polycomb Repressive Complex 2 (PRC2), including methyltransferase Ezh2, Eed, and Suz12 to enrich trimethylation of lys27 on histone H3 (H3K27me3), a gene silencing mark, at the regulatory chondrogenic gene loci. The goal of this research program is to identify how Hdac3 regulates mesenchymal identity of aortic valvular interstitial cells in both humans and mice. In addition, proposed studies will identify the mechanisms by which different kinases involved in signaling pathways regulate the phosphorylation, function, and chromatin recruitment of Hdac3. Despite intense study in the area of epigenetics, very little is known about the role of epigenetic and chromatin modifiers in the field of aortic valve biology. The set of experiments outlined in this proposal have broad significance not only for understanding how signaling pathways intersect with chromatin modifiers to regulate homeostasis of aortic valves, but also could be highly applicable to the entire field of cardiovascular diseases.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1161/circresaha.121.319587
发表时间: 2021-06-25
期刊: Circulation research
影响因子: 20.1
作者: [Janardhan HP, Saheera S, Jung R, Trivedi CM]
通讯作者: Trivedi CM
DOI: 10.1002/dvdy.24563
发表时间: 2017-12
期刊: Developmental dynamics : an official publication of the American Association of Anatomists
影响因子: --
作者: [Milstone ZJ, Lawson G, Trivedi CM]
通讯作者: Trivedi CM
DOI: 10.1172/jci.insight.153033
发表时间: 2022-09-08
期刊: JCI INSIGHT
影响因子: 8
作者: [Janardhan, Harish P., Dresser, Karen, Hutchinson, Lloyd, Trivedi, Chinmay M.]
通讯作者: Trivedi, Chinmay M.
Epigenetic regulation of lymphatic development
Epigenetic regulation of lymphatic development
Epigenetic regulation of lymphatic development
Epigenetic regulation of lymphatic development
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: